For the Inventor, By the Inventor

Enter assignee name

Malvern, PA, United States of America

Centocor, Inc.

USPTO Granted Patents = 144

CIPO Patents = 5

EPO Patents = 2

Trademarks = 5

Forward Citations = 4,128

Loading Chart...

Loading Chart...

184 inventors (with patents filed for the assignee):

David M Knight (55 out of 101 patents)

John Ghrayeb (38 out of 45 patents)

Junming Le (34 out of 37 patents)

4. Jan T Vilcek (34 out of 46 patents)

5. Peter E Daddona (33 out of 57 patents)

6. Scott A Siegel (32 out of 38 patents)

7. Jill M Giles-Komar (20 out of 56 patents)

8. George A Heavner (20 out of 37 patents)

9. Bernard Scallon (19 out of 49 patents)

10. David J Shealy (12 out of 41 patents)

11. Linda Snyder (9 out of 33 patents)

12. Mohit Trikha (9 out of 11 patents)

13. Richard T Dean (8 out of 20 patents)

14. David Peritt (7 out of 30 patents)

15. Marian Kruszynski (6 out of 7 patents)

Core Competencies:

Anti-IL-12 Antibodies

Anti-TNF Antibodies

Monoclonal Antibodies

EGFR Constructs

CXCL13 Antagonists

Human GLP-1 Mimetibody

Inflammatory Diseases

Vascular Inflammatory Pathology

Anti-Integrin Antibodies

Toll-Like Receptor 3

Mimetibody Agonists

Biomarkers

144 patents: Sort by Forward Citations

1. 8361474 - Anti-IL-12 antibody based vectors, host cells, and methods of production and uses (2013-01-29),

2. 8293882 - Anti-tissue factor antibodies and compositions (2012-10-23),

3. 8278415 - Dimeric high affinity EGFR constructs and uses thereof (2012-10-02),

4. 8277809 - CXCL13 antagonists and their use for the treatment of inflammatory diseases (2012-10-02),

5. 8241899 - Anti-TNF antibodies, compositions, methods and uses (2012-08-14),

6. 8114964 - Anti-MCP-1 antibodies, compositions, methods and uses (2012-02-14),

7. 8093068 - Methods for use in human-adapting monoclonal antibodies (2012-01-10),

8. 8071729 - Anti-integrin antibodies, compositions, methods and uses (2011-12-06),

9. 8071333 - Anti-integrin antibodies, compositions, methods and uses (2011-12-06),

10. 8071103 - Pharmaceutical composition comprising a human GLP-1 mimetibody (2011-12-06),

11. 8067191 - Method for detecting IL-16 activity and modulation of IL-16 activity based on rantes proxy protein levels (2011-11-29),

12. 8067003 - Methods of treating conditions using anti-IL-6 antibodies (2011-11-29),

13. 8043616 - sRAGE mimetibody, compositions, methods and uses (2011-10-25),

14. 7982007 - Cynomolgus toll-like receptor 3 (2011-07-19),

15. 7955597 - Anti-IL-6 antibodies, compositions, methods and uses (2011-06-07),

Centocor, Inc. is a biopharmaceutical company that focuses on researching, developing, and commercializing innovative therapies for the treatment of various diseases. They strive to provide advanced healthcare solutions that improve patients' lives and contribute to better healthcare outcomes. For more information about Centocor, please visit their official website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

144 Patents

#4 in Malvern, PA

#107 in Pennsylvania

#2,621 in US

#5,495 in the World

Malvern, PA, United States of America

Centocor, Inc.

Forward Citations = 4,128

184 inventors:

David M Knight (55 out of 101 patents)

John Ghrayeb (38 out of 45 patents)

Junming Le (34 out of 37 patents)

4. Jan T Vilcek (34 out of 46 patents)

5. Peter E Daddona (33 out of 57 patents)

Please report any incorrect information to support@idiyas.com

Loading…